Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
- Webcast Available Through Ophthotech Website -
NEW YORK--(BUSINESS WIRE)--Jan. 3, 2019--
Ophthotech
Corporation (NASDAQ: OPHT) announced today that Glenn P. Sblendorio,
Chief Executive Officer and President, will present an overview of the
Company at the 37th Annual J.P. Morgan Healthcare Conference in San
Francisco, CA on Thursday, January 10, 2019 at 10:00 a.m. Pacific Time
(1:00 p.m. Eastern Time).
Investors and the general public are invited to listen to a live webcast
of the presentation at www.ophthotech.com.
Please connect to Ophthotech’s website several minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be necessary. A replay will be available for 14 days
following the presentation.
About Ophthotech Corporation
Ophthotech is a biopharmaceutical company specializing in the
development of novel therapies to treat ophthalmic diseases, with a
focus on age-related and orphan retinal diseases. For more information,
please visit www.ophthotech.com.
Forward-looking Statements
Any statements in this press release about Ophthotech's future
expectations, plans and prospects constitute forward-looking statements
for purposes of the safe harbor provisions under the Private Securities
Litigation Reform Act of 1995. Actual results may differ materially from
those indicated by such forward-looking statements as a result of
various important factors. Any forward-looking statements represent
Ophthotech's views only as of the date of this press release. Ophthotech
anticipates that subsequent events and developments will cause its views
to change. While Ophthotech may elect to update these forward-looking
statements at some point in the future, Ophthotech specifically
disclaims any obligation to do so.
OPHT-G
View source version on businesswire.com: https://www.businesswire.com/news/home/20190103005007/en/
Source: Ophthotech Corporation
Investors
Kathy Galante
Ophthotech Corporation
Vice
President, Investor Relations and Corporate Communications
212-845-8231
kathy.galante@ophthotech.com
Media
Alex Van Rees
SmithSolve LLC on behalf of
Ophthotech Corporation
973-442-1555 ext. 111
alex.vanrees@smithsolve.com
